- Home
- / Bio Pappel
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Bio Pappel financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$27.4 B
FY, 2020
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| MXN | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 26.5B | 25.9B | 27.4B |
| Cost of goods sold | 19.9B | 17.3B | 19.0B |
| Gross profit | 6.6B | 8.6B | 8.4B |
| Gross profit margin, % | 24.9% | 33.3% | 30.5% |
| Operating expense total | 1.6B | 3.3B | 4.0B |
| Depreciation and amortization | 1.0B | 1.4B | 1.6B |
| EBITDA | 5.0B | 5.4B | 4.3B |
| EBITDA margin, % | 19.1% | 20.7% | 15.9% |
| EBIT | 4.0B | 3.9B | 2.7B |
| EBIT margin, % | 15.1% | 15.1% | 10.0% |
| Interest income | 67.6M | 93.8M | 97.0M |
| Interest expense | 1.1B | 1.2B | 953.4M |
| Pre tax profit | 3.0B | 2.8B | 1.5B |
| Income tax expense | 774.7M | 754.7M | 413.4M |
| Net Income | 2.3B | 2.0B | 1.1B |